A longstanding goal of immunotherapies and vaccine research is to induce antibodies in humans that neutralize deadly viruses such as HIV and ...
A longstanding goal of immunotherapies and vaccine research is to induce antibodies in humans that neutralize deadly viruses such as ...
One of the biggest hurdles in developing an HIV vaccine is coaxing the body to produce the right kind of immune cells and ...
Llama antibodies clamp the coronavirus shut at its weakest spot—leaving the virus powerless to mutate or infect.
Angitia Biopharmaceuticals has unveiled its second mega-round in 14 months, revealing a $130 million series D financing that positions the biotech to take three bone disease prospects deeper into the ...
Leads Biolabs is developing LBL-047, a new bispecific antibody for autoimmune diseases that targets B cells and pDCs. LBL-047 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results